MS vs CME
By Alex · Tickerpine
Morgan Stanley vs CME Group Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | CME |
|---|---|---|
| Price | $190.65 | $317.97 |
| Market cap | $297.99B | $113.81B |
| P/E ratio | 15.1 | 26.1 |
| ROE | 18.04% | 16.13% |
| Profit margin | 25.63% | 63.48% |
| Revenue growth | 10.80% | 13.00% |
| Dividend yield | 2.41% | 1.64% |
| Beta | 1.22 | 0.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs CME in plain English
- MS is the bigger company — about 2.6× the market cap of CME.
- MS is cheaper on earnings (P/E 15.1 vs 26.1).
- MS earns a higher return on equity (18% vs 16%).
- CME is growing revenue faster (13% vs 11%).
- MS has the higher dividend yield (2.41% vs 1.64%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
CME return calculator
See what $1,000 in CME Group Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.